You are here: Industry Insights > Kidney Disease

News List

Chinook Therapeutics Announces Formation of SanReno Therapeutics, a Joint Venture to Develop Kidney Disease Therapies in China, Taiwan, China and Hong Kong, S.A.R., China AmericanPharmaceuticalReview
December 01, 2021
Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced the formation of SanReno Therapeutics, a joint venture with an investor syndicate...
FDA Approves Drug to Reduce Risk of Serious Kidney and Heart Complications in Adults with Chronic Kidney Disease Associated with Type 2 Diabetes fda.gov
July 12, 2021
FDA has approved Kerendia (finerenone) tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated.
Goldfinch Bio raises $100m to develop therapies for kidney diseases pharmaceutical-business-review
July 06, 2020
Goldfinch Bio has raised $100m in a Series B funding round for the discovery and development of precision drugs for the treatment of kidney diseases.
Gilead, Goldfinch to team up against kidney disease pharmatimes
May 09, 2019
Gilead and Goldfinch Bio have collaborated to discover, develop and commercialise a pipeline of innovative therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.
Incidence of End-Stage Kidney Disease Up in Australia drugs
January 02, 2019
For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013....
Kidney Disease Risk Tied to Sugar-Sweetened Drinks drugs
December 28, 2018
People who drink lots of sugar-sweetened drinks may be putting themselves at a heightened risk for kidney disease, a new study suggests.....
Gene editing shows promise in treating inherited kidney disease fiercebiotech
November 20, 2018
Joubert syndrome, an inherited brain disorder that affects one in 80,000 newborns, causes kidney failure in about a third of patients, many of whom end up requiring a transplant or dialysis. This inherited form of kidney disease is caused by a mutation in
Outset Medical bags another $132M to ramp up U.S. expansion for all-in-one dialysis system fiercebiotech
August 30, 2018
Outset Medical's Tablo Dialysis System is FDA-cleared for use in chronic and acute care settings and is working to expand that label to include home use.
Metformin found to be safe for most diabetics with kidney disease europeanpharmaceuticalreview
June 08, 2018
Acidosis related to use of metformin seen only in those with severely decreased kidney function…
Novo Nordisk licenses kidney disease drug from Epigen fiercebiotech
May 29, 2018
Novo Nordisk has picked up the worldwide rights to a kidney disease drug in development at Epigen.

Previous page 1 2 Next page